Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

China flag China · Delayed Price · Currency is CNY
11.53
+0.03 (0.26%)
Feb 4, 2026, 3:00 PM CST
44.12%
Market Cap3.66B +46.3%
Revenue (ttm)790.86M +7.9%
Net Income226.35M +36.3%
EPS0.70 +37.4%
Shares Out317.69M
PE Ratio16.45
Forward PEn/a
Dividend0.25 (2.17%)
Ex-Dividend DateJun 18, 2025
Volume3,546,640
Average Volume10,780,750
Open11.50
Previous Close11.50
Day's Range11.43 - 11.64
52-Week Range7.21 - 16.97
Beta0.12
RSI48.85
Earnings DateApr 24, 2026

About SHA:603811

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 1966
Employees 637
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603811
Full Company Profile

Financial Performance

In 2024, SHA:603811's revenue was 714.37 million, an increase of 6.36% compared to the previous year's 671.63 million. Earnings were 200.70 million, an increase of 23.21%.

Financial Statements